Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Case report

Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease – a case report

Authors: Veronika Elisakova, Miroslav Merta, Jana Reiterova, Alica Baxova, Jaroslav Kotlas, Katerina Hirschfeldova, Lena Obeidova, Vladimir Tesar, Jitka Stekrova

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary renal disorder, leading to end stage renal failure and kidney transplantation in its most serious form. The severity of the disease’s manifestation depends on the genetic determination of ADPKD. The huge variability of different phenotypes (even within a single family) is not only modulated by the two main ADPKD genes (PKD1 and PKD2) but also by modifier genes and the whole genetic background.

Case presentation

This is a report of an ADPKD family with co-inheritance of PKD1 and PKD2 pathogenic variants. The proband, with an extremely serious manifestation of ADPKD (the man was diagnosed in early childhood, and with end stage renal disease aged 23), underwent genetic analysis of PKD1 and PKD2, which revealed the presence of pathogenic mutations in both of these genes. The missense PKD2 mutation p.Arg420Gly came from the proband’s father, with a mild ADPKD phenotype. The same mutation of the PKD2 gene and similar mild disease presentation were found in the proband’s aunt (father’s sister) and her son. The nonsense mutation p.Gln2196* within the PKD1 gene was probably inherited from the proband’s mother, who died at the age of 45. It was only discovered post mortem, that the real cause of her death was kidney failure as a consequence of untreated ADPKD. Unfortunately, neither the DNA of the proband’s mother nor the DNA of any other family members from this side of the pedigree were available for further examination. The proband underwent successful cadaveric kidney transplantation at the age of 24, and this replacement therapy lasted for the next 15 years.

Conclusions

Here, we present a first case of bilineal ADPKD inheritance in the Czech Republic. This report highlights the significant role of modifier genes in genetic determination of ADPKD, especially in connection with seriously deteriorated disease phenotypes. In our case, the modifying role is probably mediated by the PKD2 gene.
Literature
1.
go back to reference Cordido A, Besada-Cerecedo L, García-González MA. The genetic and cellular basis of autosomal dominant polycystic kidney disease-a primer for clinicians. Front Pediatr. 2017;5:279.CrossRefPubMedPubMedCentral Cordido A, Besada-Cerecedo L, García-González MA. The genetic and cellular basis of autosomal dominant polycystic kidney disease-a primer for clinicians. Front Pediatr. 2017;5:279.CrossRefPubMedPubMedCentral
2.
3.
go back to reference Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, et al. Autosomal dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2015;88(1):17–27.CrossRefPubMedPubMedCentral Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, et al. Autosomal dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2015;88(1):17–27.CrossRefPubMedPubMedCentral
4.
go back to reference European Polycystic Kidney Disease Consortium. The polycystic kidney disease I gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell. 1994;77:881–94.CrossRef European Polycystic Kidney Disease Consortium. The polycystic kidney disease I gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell. 1994;77:881–94.CrossRef
5.
go back to reference Kimberling WJ, Kumar S, Gabow PA, Kenyon JB, Connolly CJ, Somlo S. Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics. 1993;18:467–72.CrossRefPubMed Kimberling WJ, Kumar S, Gabow PA, Kenyon JB, Connolly CJ, Somlo S. Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics. 1993;18:467–72.CrossRefPubMed
6.
go back to reference Tan YC, Blumenfeld J, Rennert H. Autosomal dominant polycystic kidney disease: genetics, mutations and microRNAs. Biochim Biophys Acta. 2011;1812(10):1202–12.CrossRefPubMed Tan YC, Blumenfeld J, Rennert H. Autosomal dominant polycystic kidney disease: genetics, mutations and microRNAs. Biochim Biophys Acta. 2011;1812(10):1202–12.CrossRefPubMed
7.
go back to reference Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet. 2003;33:129–37.CrossRefPubMed Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet. 2003;33:129–37.CrossRefPubMed
8.
go back to reference Trudel M. C-Myc Signalling in the genetic mechanism of polycystic kidney disease. In: Li X, editor. Polycystic kidney disease. Brisbane: Codon Publications; 2015. Chapter 10. Trudel M. C-Myc Signalling in the genetic mechanism of polycystic kidney disease. In: Li X, editor. Polycystic kidney disease. Brisbane: Codon Publications; 2015. Chapter 10.
9.
11.
go back to reference Riella C, Czarnecki PG, Steinman TI. Therapeutic advances in the treatment of polycystic kidney disease. Nephron Clin Pract. 2014;128(3–4):297–302.PubMed Riella C, Czarnecki PG, Steinman TI. Therapeutic advances in the treatment of polycystic kidney disease. Nephron Clin Pract. 2014;128(3–4):297–302.PubMed
12.
go back to reference Saigusa T, Bell PD. Molecular pathways and therapies in autosomal-dominant polycystic kidney disease. Physiology (Bethesda). 2015;30(3):195–207. Saigusa T, Bell PD. Molecular pathways and therapies in autosomal-dominant polycystic kidney disease. Physiology (Bethesda). 2015;30(3):195–207.
13.
go back to reference de Stephanis L, Bonon A, Varani K, Lanza G, Gafà R, Pinton P, et al. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells. Clin Exp Nephrol. 2017;21(2):203–11.CrossRefPubMed de Stephanis L, Bonon A, Varani K, Lanza G, Gafà R, Pinton P, et al. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells. Clin Exp Nephrol. 2017;21(2):203–11.CrossRefPubMed
14.
go back to reference Streets AJ, Magayr TA, Huang L, Vergoz L, Rossetti S, Simms RJ, et al. Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression. Am J Physiol Renal Physiol. 2017;312(4):F577–88.CrossRefPubMedPubMedCentral Streets AJ, Magayr TA, Huang L, Vergoz L, Rossetti S, Simms RJ, et al. Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression. Am J Physiol Renal Physiol. 2017;312(4):F577–88.CrossRefPubMedPubMedCentral
15.
go back to reference Wong ATY, Mannix C, Grantham JJ, Allman-Farinelli M, Badve SV, Boudville N, et al. Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD). BMJ Open. 2018;8(1):e018794.PubMedPubMedCentral Wong ATY, Mannix C, Grantham JJ, Allman-Farinelli M, Badve SV, Boudville N, et al. Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD). BMJ Open. 2018;8(1):e018794.PubMedPubMedCentral
16.
go back to reference Cornec-Le Gall E, Audrézet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, et al. Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol. 2013;24(6):1006–13.CrossRefPubMedPubMedCentral Cornec-Le Gall E, Audrézet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, et al. Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol. 2013;24(6):1006–13.CrossRefPubMedPubMedCentral
17.
go back to reference Cornec-Le Gall E, Audrézet MP, Renaudineau E, Hourmant M, Charasse C, Michez E, et al. PKD2-related autosomal dominant polycystic kidney disease: prevalence, clinical presentation, mutation Spectrum, and prognosis. Am J Kidney Dis. 2017;70(4):476–85.CrossRefPubMed Cornec-Le Gall E, Audrézet MP, Renaudineau E, Hourmant M, Charasse C, Michez E, et al. PKD2-related autosomal dominant polycystic kidney disease: prevalence, clinical presentation, mutation Spectrum, and prognosis. Am J Kidney Dis. 2017;70(4):476–85.CrossRefPubMed
18.
go back to reference Consugar MB, Wong WC, Lundquist PA, Rossetti S, Kubly VJ, Walker DL, et al. Characterization of large rearrangements in autosomal dominant polycystic kidney dinase and the PKD1/TSC2 contiguous gene syndrome. Kidney Int. 2008;74:1468–79.CrossRefPubMedPubMedCentral Consugar MB, Wong WC, Lundquist PA, Rossetti S, Kubly VJ, Walker DL, et al. Characterization of large rearrangements in autosomal dominant polycystic kidney dinase and the PKD1/TSC2 contiguous gene syndrome. Kidney Int. 2008;74:1468–79.CrossRefPubMedPubMedCentral
19.
go back to reference Reiterová J, Štekrová J, Merta M, Kotlas J, Elišáková V, Lněnička P, et al. Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele. BMC Nephrol. 2013;14:59.CrossRefPubMedPubMedCentral Reiterová J, Štekrová J, Merta M, Kotlas J, Elišáková V, Lněnička P, et al. Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele. BMC Nephrol. 2013;14:59.CrossRefPubMedPubMedCentral
20.
go back to reference Pei Y, Paterson AD, Wang KR, He N, Hefferton D, Watnick T, et al. Bilineal disease and trans heterozygotes in autosomal dominant polycystic kidney disease. Am J Hum Genet. 2001;68:355–63.CrossRefPubMedPubMedCentral Pei Y, Paterson AD, Wang KR, He N, Hefferton D, Watnick T, et al. Bilineal disease and trans heterozygotes in autosomal dominant polycystic kidney disease. Am J Hum Genet. 2001;68:355–63.CrossRefPubMedPubMedCentral
21.
go back to reference Vujic M, Heyer CM, Ars E, Hopp K, Markoff A, Orndal C, et al. Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD. JAm Soc Nephrol. 2010;21:1097–102.CrossRef Vujic M, Heyer CM, Ars E, Hopp K, Markoff A, Orndal C, et al. Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD. JAm Soc Nephrol. 2010;21:1097–102.CrossRef
22.
go back to reference Porath B, Gainullin VG, Cornec-Le Gall E, Dillinger EK, Heyer CM, Hopp K, et al. Mutations in GANAB, encoding the glucosidase IIα subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet. 2016;98(6):1193–207.CrossRefPubMedPubMedCentral Porath B, Gainullin VG, Cornec-Le Gall E, Dillinger EK, Heyer CM, Hopp K, et al. Mutations in GANAB, encoding the glucosidase IIα subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet. 2016;98(6):1193–207.CrossRefPubMedPubMedCentral
23.
go back to reference Stekrová J, Reiterová J, Merta M, Damborsky J, Zidovská J, Kebrdlová V, et al. PKD2 mutations in a Czech population with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2004;19(5):1116–22.CrossRefPubMed Stekrová J, Reiterová J, Merta M, Damborsky J, Zidovská J, Kebrdlová V, et al. PKD2 mutations in a Czech population with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2004;19(5):1116–22.CrossRefPubMed
24.
go back to reference Obeidova L, Elisakova V, Stekrova J, Reiterova J, Merta M, Tesar V, et al. Novel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease. BMC Med Genet. 2014;15:41.CrossRefPubMedPubMedCentral Obeidova L, Elisakova V, Stekrova J, Reiterova J, Merta M, Tesar V, et al. Novel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease. BMC Med Genet. 2014;15:41.CrossRefPubMedPubMedCentral
25.
go back to reference Moorchung N. Molecular techniques in preimplantation genetic diagnosis. In: Talwar CP, editor. Manual of Cytogenetics in Reproductive Biology. Jaypee Brothers Medical Publishers; 2014. p.73-86. Moorchung N. Molecular techniques in preimplantation genetic diagnosis. In: Talwar CP, editor. Manual of Cytogenetics in Reproductive Biology. Jaypee Brothers Medical Publishers; 2014. p.73-86.
26.
go back to reference Bergmann C, von Bothmer J, Ortiz Brüchle N, Venghaus A, Frank V, Fehrenbach H, et al. Mutations in multiple PKD genes may explain early and severe polycystic kidney disease. J Am Soc Nephrol. 2011;22:2047–56.CrossRefPubMedPubMedCentral Bergmann C, von Bothmer J, Ortiz Brüchle N, Venghaus A, Frank V, Fehrenbach H, et al. Mutations in multiple PKD genes may explain early and severe polycystic kidney disease. J Am Soc Nephrol. 2011;22:2047–56.CrossRefPubMedPubMedCentral
27.
go back to reference Bergmann C. ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies. Pediatr Nephrol. 2015;30(1):15–30.CrossRefPubMed Bergmann C. ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies. Pediatr Nephrol. 2015;30(1):15–30.CrossRefPubMed
28.
go back to reference Dedoussis GV, Luo Y, Starremans P, Rossetti S, Ramos AJ, Cantiello HF, et al. Co-inheritance of a PKD1 mutation and homozygous PKD2 variant: a potential modifier in autosomal dominant polycystic kidney disease. Eur J Clin Investig. 2008;38(3):180–90.CrossRef Dedoussis GV, Luo Y, Starremans P, Rossetti S, Ramos AJ, Cantiello HF, et al. Co-inheritance of a PKD1 mutation and homozygous PKD2 variant: a potential modifier in autosomal dominant polycystic kidney disease. Eur J Clin Investig. 2008;38(3):180–90.CrossRef
30.
go back to reference Ali H, Hussain N, Naim M, Zayed M, Al-Mulla F, Kehinde EO, et al. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease. BMC Nephrol. 2015;16:26.CrossRefPubMedPubMedCentral Ali H, Hussain N, Naim M, Zayed M, Al-Mulla F, Kehinde EO, et al. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease. BMC Nephrol. 2015;16:26.CrossRefPubMedPubMedCentral
31.
go back to reference Rossetti S, Kubly VJ, Consugar MB, Hopp K, Roy S, Horsley SW, et al. Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int. 2009;75(8):848–55.CrossRefPubMedPubMedCentral Rossetti S, Kubly VJ, Consugar MB, Hopp K, Roy S, Horsley SW, et al. Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int. 2009;75(8):848–55.CrossRefPubMedPubMedCentral
32.
go back to reference Audrézet MP, Corbiere C, Lebbah S, Morinière V, Broux F, Louillet F, et al. Comprehensive PKD1 and PKD2 mutation analysis in prenatal autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2016;27(3):722–9.CrossRefPubMed Audrézet MP, Corbiere C, Lebbah S, Morinière V, Broux F, Louillet F, et al. Comprehensive PKD1 and PKD2 mutation analysis in prenatal autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2016;27(3):722–9.CrossRefPubMed
33.
go back to reference Fain PR, McFann KK, Taylor MR, Tison M, Johnson AM, Reed B, et al. Modifier genes play a significant role in the phenotypic expression of PKD1. Kidney Int. 2005;67(4):1256–67.CrossRefPubMed Fain PR, McFann KK, Taylor MR, Tison M, Johnson AM, Reed B, et al. Modifier genes play a significant role in the phenotypic expression of PKD1. Kidney Int. 2005;67(4):1256–67.CrossRefPubMed
34.
go back to reference Pei Y, Lan Z, Wang K, Garcia-Gonzalez M, He N, Dicks E, et al. A missense mutation in PKD1 attenuates the severity of renal disease. Kidney Int. 2012;81(4):412–7.CrossRefPubMed Pei Y, Lan Z, Wang K, Garcia-Gonzalez M, He N, Dicks E, et al. A missense mutation in PKD1 attenuates the severity of renal disease. Kidney Int. 2012;81(4):412–7.CrossRefPubMed
35.
go back to reference Hwang YH, Conklin J, Chan W, Roslin NM, Liu J, He N, et al. Refining genotype-phenotype correlation in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2016;27(6):1861–8.CrossRefPubMed Hwang YH, Conklin J, Chan W, Roslin NM, Liu J, He N, et al. Refining genotype-phenotype correlation in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2016;27(6):1861–8.CrossRefPubMed
36.
go back to reference Bullich G, Vargas I, Trujillano D, Mendizábal S, Piñero-Fernández JA, Fraga G, et al. Contribution of the TTC21B gene to glomerular and cystic kidney diseases. Nephrol Dial Transplant. 2017;32(1):151–6.PubMed Bullich G, Vargas I, Trujillano D, Mendizábal S, Piñero-Fernández JA, Fraga G, et al. Contribution of the TTC21B gene to glomerular and cystic kidney diseases. Nephrol Dial Transplant. 2017;32(1):151–6.PubMed
37.
go back to reference Eisenberger T, Decker C, Hiersche M, Hamann RC, Decker E, Neuber S, et al. An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease. PLoS One. 2015;10(2):e0116680.CrossRefPubMedPubMedCentral Eisenberger T, Decker C, Hiersche M, Hamann RC, Decker E, Neuber S, et al. An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease. PLoS One. 2015;10(2):e0116680.CrossRefPubMedPubMedCentral
38.
go back to reference Kinoshita M, Higashihara E, Kawano H, Higashiyama R, Koga D, Fukui T, et al. Technical evaluation: identification of pathogenic mutations in PKD1 and PKD2 in patients with autosomal dominant polycystic kidney disease by next-generation sequencing and use of a comprehensive new classification system. PLoS One. 2016;11(11):e0166288.CrossRefPubMedPubMedCentral Kinoshita M, Higashihara E, Kawano H, Higashiyama R, Koga D, Fukui T, et al. Technical evaluation: identification of pathogenic mutations in PKD1 and PKD2 in patients with autosomal dominant polycystic kidney disease by next-generation sequencing and use of a comprehensive new classification system. PLoS One. 2016;11(11):e0166288.CrossRefPubMedPubMedCentral
39.
go back to reference Liu M, Shi S, Senthilnathan S, Yu J, Wu E, Bergmann C, et al. Genetic variation of DKK3 may modify renal disease severity in ADPKD. J Am Soc Nephrol. 2010;21(9):1510–20.CrossRefPubMedPubMedCentral Liu M, Shi S, Senthilnathan S, Yu J, Wu E, Bergmann C, et al. Genetic variation of DKK3 may modify renal disease severity in ADPKD. J Am Soc Nephrol. 2010;21(9):1510–20.CrossRefPubMedPubMedCentral
Metadata
Title
Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease – a case report
Authors
Veronika Elisakova
Miroslav Merta
Jana Reiterova
Alica Baxova
Jaroslav Kotlas
Katerina Hirschfeldova
Lena Obeidova
Vladimir Tesar
Jitka Stekrova
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-0978-2

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue